- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:20 | GSK to ramp up vaccine adjuvant production to 1bn doses | ||
| Do | Thermo Fisher takes over operation of $1bn CSL facility | ||
| Do | Gilead seals $2bn deal for Arcus' pipeline | ||
| Mi | Hired and Retired: Biotechs buildout at board level | ||
| Di | AbCellera in COVID-19 antibody discovery pact with Eli Lilly | ||
| Di | Sanofi set to sell Regeneron shares worth $13bn | ||
| Di | Merck leaps into COVID-19 battle with three developments | ||
| Mo | WuXi AppTec launches closed process CAR-T platform | ||
| Mo | Samsung Biologics enters eight-year partnership with GSK | ||
| 22.05. | AZ receives $1.2bn from BARDA for coronavirus vaccine | ||
| 21.05. | Novartis' gene therapy approved in Europe, talks ongoing on price | ||
| 21.05. | WuXi Biologics seals deal for first US production facility | ||
| 20.05. | Tracking the latest therapies for COVID-19 | ||
| 19.05. | UK injects funds into COVID-19 vaccine, puts citizens front of queue | ||
| 19.05. | Moderna COVID-19 vaccine results not possible 'so fast' alongside CMO | ||
| 19.05. | Immunai unveils map of human immune system | ||
| 18.05. | Sanofi retracts US-first stance on COVID-19 vaccine | ||
| 18.05. | Thermo Fisher set to build $180m viral vector site | ||
| 18.05. | US outlines plan for readying coronavirus vaccine by start of 2021 | ||
| 14.05. | FDA refuses to file BMS treatment over manufacturing concerns | ||
| 14.05. | Biotech launches to create 'rationally' designed gene therapy | ||
| 13.05. | US strikes $138m deal to ensure enough syringes for COVID-19 vaccine | ||
| 12.05. | BMS spends $200m to buy bluebird out of CAR-T payments | ||
| 12.05. | Pfizer to outsource brand products, making space for COVID-19 vaccine | ||
| 12.05. | Novavax receives record $388m funding for COVID-19 vaccine |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
